In transgenic mice with increased skeletal muscle-specific UCP1 expression, UCP1 activity showed great potential to reduce obesity and inflammation by accelerating skeletal muscle metabolism and energy expenditure. The gene discussed is UCP1; the disease is obesity disorder.